Published by Josh White on 25th May 2021
(Sharecast News) - Cell-based therapy developer MaxCyte announced the signing of a strategic platform licence with clinical-stage biotechnology company Celularity on Tuesday.
URL: http://www.digitallook.com/dl/news/story/31871978/...